Literature DB >> 19446769

Effect of homobifunctional crosslinkers on nucleic acids delivery ability of PEI nanoparticles.

Archana Swami1, Ritu Goyal, Sushil Kumar Tripathi, Naresh Singh, Neeraj Katiyar, Anil K Mishra, K C Gupta.   

Abstract

Polyethylenimine (PEI), a widely used cationic polymeric vector with high transfection efficiency, was converted into nanoparticles by introducing ionic and covalent crosslinkers with varying proportion of 1,6-hexanebisphosphate (HP), adipic acid (AA) and 1,4-butane dialdehyde (BA) to obtain a small library of HP-PEI (HPP), AA-PEI (AAP) and BA-PEI (BAP) nanoparticles, respectively. Particles were characterized by spectroscopic technique as well as physicochemical parameters such as size, morphology, surface charge, effect of crosslinking on buffering capacity and DNA binding ability. The entire series of nanoparticles were compared for their cytoxicity and ability to deliver genes in various cell lines. Among various nanoparticles, AAP-3 nanoparticle/DNA complex exhibited higher transfection efficiency (1.5-7.8 folds) than the native PEI (25kDa) and commercially available transfection reagents, such as GenePorter, GenePorter2, Fugene and Superfect, with cell viability >85%. The highest cell viability was observed with BAP nanoparticles (>95%). Importantly, the transfection activity of nanoparticle/DNA complexes was preserved in the presence of serum. Transfection with GFP-siRNA inhibited expression of transfected GFP gene by approximately 81-92%. All nanoparticle types (HPP, AAP and BAP) required a comparable time for entry into cells and subsequent intracellular passage from the cytoplasm to the nucleus. Intravenous delivery of (99)Tc labeled BAP-2/DNA complex to female Balb/c mice revealed the presence of the complex in most of the organs with the highest retention in liver. In conclusion, HPP, AAP and BAP nanoparticles are safe for efficient gene delivery.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19446769     DOI: 10.1016/j.ijpharm.2009.03.009

Source DB:  PubMed          Journal:  Int J Pharm        ISSN: 0378-5173            Impact factor:   5.875


  9 in total

1.  Transfecting the hard-to-transfect lymphoma/leukemia cells using a simple cationic polymer nanocomplex.

Authors:  Nianxi Zhao; Jianjun Qi; Zihua Zeng; Parag Parekh; Chung-Che Chang; Ching-Hsuan Tung; Youli Zu
Journal:  J Control Release       Date:  2012-01-15       Impact factor: 9.776

2.  In Vitro TyRP-1 Knockdown Based on siRNA Carried by Liquid Crystalline Nanodispersions: an Alternative Approach for Topical Treatment of Vitiligo.

Authors:  Larissa Bueno Tofani; Lívia Vieira Depieri; Patrícia Mazureki Campos; Thalita Bachelli Riul; Kamilla Swiech Antonietto; Márcia Carvalho de Abreu Fantini; Maria Vitória Lopes Badra Bentley
Journal:  Pharm Res       Date:  2018-03-20       Impact factor: 4.200

Review 3.  Nanotoxicity: a key obstacle to clinical translation of siRNA-based nanomedicine.

Authors:  Hui Yi Xue; Shimeng Liu; Ho Lun Wong
Journal:  Nanomedicine (Lond)       Date:  2014-02       Impact factor: 5.307

4.  A nanocomplex that is both tumor cell-selective and cancer gene-specific for anaplastic large cell lymphoma.

Authors:  Nianxi Zhao; Hitesh G Bagaria; Michael S Wong; Youli Zu
Journal:  J Nanobiotechnology       Date:  2011-01-31       Impact factor: 10.435

5.  Layer-by-layer assembled gold nanoshells for the intracellular delivery of miR-34a.

Authors:  Ritu Goyal; Chintan H Kapadia; Jilian R Melamed; Rachel S Riley; Emily S Day
Journal:  Cell Mol Bioeng       Date:  2018-06-06       Impact factor: 2.321

6.  Synthesis and evaluation of tetramethylguanidinium-polyethylenimine polymers as efficient gene delivery vectors.

Authors:  Manohar Mahato; Santosh Yadav; Pradeep Kumar; Ashwani Kumar Sharma
Journal:  Biomed Res Int       Date:  2014-04-24       Impact factor: 3.411

Review 7.  Lipid-Based Nanocarriers for RNA Delivery.

Authors:  Hui Yi Xue; Pengbo Guo; Wu-Cheng Wen; Ho Lun Wong
Journal:  Curr Pharm Des       Date:  2015       Impact factor: 3.116

Review 8.  Nanopharmacology in translational hematology and oncology.

Authors:  Ciprian Tomuleasa; Cornelia Braicu; Alexandra Irimie; Lucian Craciun; Ioana Berindan-Neagoe
Journal:  Int J Nanomedicine       Date:  2014-07-22

Review 9.  Oligonucleotide Aptamer-Mediated Precision Therapy of Hematological Malignancies.

Authors:  Shuanghui Yang; Huan Li; Ling Xu; Zhenhan Deng; Wei Han; Yanting Liu; Wenqi Jiang; Youli Zu
Journal:  Mol Ther Nucleic Acids       Date:  2018-09-06       Impact factor: 8.886

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.